Fenebrutinib (GDC-0853)
98%
- Product Code: 108285
CAS:
1434048-34-6
| Molecular Weight: | 664.80 g./mol | Molecular Formula: | C₃₇H₄₄N₈O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Fenebrutinib is primarily investigated for its potential in treating autoimmune diseases, particularly rheumatoid arthritis and systemic lupus erythematosus. It works by selectively inhibiting Bruton's tyrosine kinase (BTK), a key enzyme involved in B-cell signaling pathways. By blocking BTK, it helps reduce the activation and proliferation of B-cells, which play a critical role in the immune response and inflammation associated with these conditions. Clinical trials are ongoing to evaluate its efficacy and safety, with promising early results suggesting it could offer a targeted therapeutic option for patients with limited response to conventional treatments. Additionally, its potential applications extend to other B-cell-mediated disorders, making it a versatile candidate in immunology research.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿13,644.00 |
+
-
|
Fenebrutinib (GDC-0853)
Fenebrutinib is primarily investigated for its potential in treating autoimmune diseases, particularly rheumatoid arthritis and systemic lupus erythematosus. It works by selectively inhibiting Bruton's tyrosine kinase (BTK), a key enzyme involved in B-cell signaling pathways. By blocking BTK, it helps reduce the activation and proliferation of B-cells, which play a critical role in the immune response and inflammation associated with these conditions. Clinical trials are ongoing to evaluate its efficacy and safety, with promising early results suggesting it could offer a targeted therapeutic option for patients with limited response to conventional treatments. Additionally, its potential applications extend to other B-cell-mediated disorders, making it a versatile candidate in immunology research.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :